BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Maar JS, Sofias AM, Porta Siegel T, Vreeken RJ, Moonen C, Bos C, Deckers R. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment. Theranostics 2020;10:1884-909. [PMID: 32042343 DOI: 10.7150/thno.38625] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Zhang W. The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis. J Control Release 2022:S0168-3659(22)00189-4. [PMID: 35367478 DOI: 10.1016/j.jconrel.2022.03.056] [Reference Citation Analysis]
2 Sofias AM, Combes F, Koschmieder S, Storm G, Lammers T. A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system. Drug Discov Today 2021;26:1482-9. [PMID: 33617793 DOI: 10.1016/j.drudis.2021.02.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sofias AM, Bjørkøy G, Ochando J, Sønstevold L, Hegvik M, Davies CDL, Haraldseth O, Lammers T, Mulder WJM, Hak S. Cyclic Arginine–Glycine–Aspartate‐Decorated Lipid Nanoparticle Targeting toward Inflammatory Lesions Involves Hitchhiking with Phagocytes. Advanced Science 2021;8:2100370. [DOI: 10.1002/advs.202100370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zou H, Li M, Li X, Zheng W, Kuang H, Wang M, Zhang W, Ran H, Ma H, Zhou X. Multimodal imaging and photothermal synergistic immunotherapy of retinoblastoma with tuftsin-loaded carbonized MOF nanoparticles. Drug Deliv 2022;29:1785-99. [PMID: 35642917 DOI: 10.1080/10717544.2022.2081379] [Reference Citation Analysis]
5 Jiao X, Sun L, Zhang W, Ren J, Zhang L, Cao Y, Xu Z, Kang Y, Xue P. Engineering oxygen-deficient ZrO2-x nanoplatform as therapy-activated "immunogenic cell death (ICD)" inducer to synergize photothermal-augmented sonodynamic tumor elimination in NIR-II biological window. Biomaterials 2021;272:120787. [PMID: 33819815 DOI: 10.1016/j.biomaterials.2021.120787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Strittmatter N, England RM, Race AM, Sutton D, Moss JI, Maglennon G, Ling S, Wong E, Rose J, Purvis I, Macdonald R, Barry ST, Ashford MB, Goodwin RJA. Method to Investigate the Distribution of Water-Soluble Drug-Delivery Systems in Fresh Frozen Tissues Using Imaging Mass Cytometry. Anal Chem 2021;93:3742-9. [PMID: 33606520 DOI: 10.1021/acs.analchem.0c03908] [Reference Citation Analysis]
7 Bastiancich C, Malfanti A, Préat V, Rahman R. Rationally designed drug delivery systems for the local treatment of resected glioblastoma. Adv Drug Deliv Rev 2021;177:113951. [PMID: 34461201 DOI: 10.1016/j.addr.2021.113951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Shi Y, van der Meel R, Chen X, Lammers T. The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. Theranostics 2020;10:7921-4. [PMID: 32685029 DOI: 10.7150/thno.49577] [Cited by in Crossref: 190] [Cited by in F6Publishing: 149] [Article Influence: 95.0] [Reference Citation Analysis]
9 Nicolson F, Ali A, Kircher MF, Pal S. DNA Nanostructures and DNA-Functionalized Nanoparticles for Cancer Theranostics. Adv Sci (Weinh) 2020;7:2001669. [PMID: 33304747 DOI: 10.1002/advs.202001669] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
10 Yilmaz D, Sharp PS, Main MJ, Simpson PB. Advanced molecular imaging for the characterisation of complex medicines. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.03.001] [Reference Citation Analysis]
11 de Maar JS, Rousou C, van Elburg B, Vos HJ, Lajoinie GPR, Bos C, Moonen CTW, Deckers R. Ultrasound-Mediated Drug Delivery With a Clinical Ultrasound System: In Vitro Evaluation. Front Pharmacol 2021;12:768436. [PMID: 34737709 DOI: 10.3389/fphar.2021.768436] [Reference Citation Analysis]
12 Lorkowski ME, Atukorale PU, Ghaghada KB, Karathanasis E. Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy. Adv Healthc Mater 2021;10:e2001044. [PMID: 33225633 DOI: 10.1002/adhm.202001044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
13 Zhang J, Hong Y, Xie P, Chen Y, Jiang L, Yang Z, Cao G, Chen Z, Liu X, Chen Y, Wu Y, Cai Z. Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice. Front Pharmacol 2020;11:593815. [PMID: 33597874 DOI: 10.3389/fphar.2020.593815] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fletcher NL, Kempe K, Thurecht KJ. Next-Generation Polymeric Nanomedicines for Oncology: Perspectives and Future Directions. Macromol Rapid Commun 2020;41:e2000319. [PMID: 32767396 DOI: 10.1002/marc.202000319] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
15 Bernal A, Calcagno C, Mulder WJM, Pérez-Medina C. Imaging-guided nanomedicine development. Curr Opin Chem Biol 2021;63:78-85. [PMID: 33735814 DOI: 10.1016/j.cbpa.2021.01.014] [Reference Citation Analysis]
16 Glassman PM, Myerson JW, Ferguson LT, Kiseleva RY, Shuvaev VV, Brenner JS, Muzykantov VR. Targeting drug delivery in the vascular system: Focus on endothelium. Adv Drug Deliv Rev 2020;157:96-117. [PMID: 32579890 DOI: 10.1016/j.addr.2020.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]